Brief: FDA Identified Getinge's Recall Of Vaporizer Sevoflurane Maquet Filling As Class I Recall
June 13 (Reuters) - Getinge AB GETIb.ST :
* FDA:GETINGE RECALLS VAPORIZER SEVOFLURANE MAQUET FILLING
FOR
RISK OF PATIENT AND HEALTH CARE PROFESSIONAL EXPOSURE TO TOXIC
CHEMICAL HYDROGEN FLUORIDE
* FDA: IDENTIFIED GETINGE'S RECALL OF VAPORIZER SEVOFLURANE
MAQUET
FILLING AS CLASS I RECALL
Further company coverage: GETIb.ST
((reuters.briefs@thomsonreuters.com;))
Recent news on Getinge publ AB
See all newsBrief: CEO Buys SEK 4.7 Million Of Getinge Shares
Johnson & Johnson defeats heart-pump patent claims in US trial (updated)
Johnson & Johnson defeats heart-pump patent claims in US trial
Brief: Getinge's Subsidiary Maquet Cardiovascular Receives Adverse Jury Trial Verdict In Patent Infringement Dispute With Abiomed In U.S.
Getinge lags profit estimates as uncertainty curbs investments in medical equipment